Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-05-27
2008-05-27
Kemmerer, Elizabeth C. (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S007600, C514S008100, C514S012200
Reexamination Certificate
active
11243619
ABSTRACT:
Methods and kits are provided for manipulating and predicting the reproductive capacity of a female subject. The presence of endogenous neurotrophins and addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF, increase the reproductive capacity of a female patient by binding to receptors on the oocytes and stimulating maturation of the oocytes. Administration of antagonists act as a contraceptive because the antagonists prevent the neurotrophins from binding to oocyte receptors. Neurotrophins may also be used to stimulate the maturation of oocyte in vitro.
REFERENCES:
patent: 0 958 831 (1999-11-01), None
patent: WO 93/25684 (1993-12-01), None
Fedorushchenko et al. Russian Journal of Developmental Biology. 30; 1999: 395-397.
Website at glaucoma.org/learn/glaucoma—facts.html, downloaded Sep. 6, 2007; pp 1-3.
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Nebreda, et al. Induction by NGF of Meiotic Maturation of Xenopus Oocytes Expressing the trk Proto-Oncogene Product. Science. Apr. 26, 1991. vol. 252, No. 5005, pp. 558-561.
Anderson et al., “Neurotropins and Their Receptors Are Expressed in the Human Fetal Ovary,” J. Clin. Endocrinol. Metab., vol. 87, No. 2 (2002) pp. 890-897.
Conover et al., “Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4,” Nature, vol. 375, (May 18, 1995) pp. 235-238.
Dissen et al, “Direct effects of nerve growth factor on thecal cells from antral ovarian follicles,” Endrocrinology, vol. 141, No. 12 (2000) pp. 4736-4750.
Dissen et al., “Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogenesis,” Endocrinology, vol. 136, No. 10 (1995) pp. 4681-4692.
Dissen et al., “Participation of nerve growth factor in the regulation of ovarian function,” Zygote, vol. 4, (Nov. 1998) pp. 309-312.
Dissen et al., “A role forTrkA nerve growth factor receptors in mammalian ovulation,” Endocrinology, vol. 137, No. 1, (1996) pp. 198-209.
Giudice et al., “Growth Factors in Normal Ovarian Follicle Development,” Semin. Reprod. Endocrinol., vol. 14, No. 3 (Aug. 1996) pp. 179-196.
Lara et al., “The gene encoding nerve growth factor is expressed in the immature rat ovary: effect of denervation and hon-nonal treatment,” Endocrinology, vol. 126, No. 1 (1990) pp. 357-363.
Lara et al., “Involvement of nerve growth in female sexual development,” Endocrinology, vol. 126, No. 1 (1990) pp. 364-375.
Mayerhofer et al., “Involvement of nerve growth factor in the ovulatory cascade:trkA receptor activation inhibits gap junctional communication between thecal cells,” Endocrinology, vol. 137, No. 12 (1996) pp. 5662-5670.
Mischel et al., “The extracellular domain of p75NTRis necessary to inhibit neurotrophin-3 signaling through TrkA,” J. Biol. Chem., vol. 276, No. 14 (Apr. 6, 2001) pp. 11294-11301.
Ojeda et al., “Neurotrophic and cell—cell dependent control of early follicular development,” Mol Cell Endo., vol. 163, (2000) pp. 67-71.
Parvinen et al., “Expression of β-nerve growth factor and its receptor in rat seminiferous epithelium: specific function at the onset of melosis,” J. Cell. Biol., vol. 117, (1992) pp. 629-641.
Promega Technical Bulletin #257, “BDNF Emax™ ImmunoAssay System,” Madison, WI, Revised (Jan. 1998).
Reichardt et al., “in Molecular Approaches to Neuronal Development,” Cowan et al., eds., Oxford University Press, New York, (1997) pp. 220-263.
Schneyer et al., “Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations,” J. Clin. Endocrinol. Metab., vol. 85, No. 9 (2000) pp. 3319-3330.
Seidl et al., “Expression of nerve growth factor and neurotrophin receptors in testicular cells suggest novel roles for neurotrophins outside the nervous system,” Reprod. Fert. Dev., vol. 8, (1996) pp. 1075-1087.
Seifer et al., “Brain-derived neurotrophic factor (BDNF): A noval human ovarian follicular protein,” J. Clin. Endocrinol. Metab., vol. 87, No. 2 (2002) pp. 655-659.
Seifer et al., “Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve,” J. Clin. Endocrinol. Metab., vol. 81, (1996) pp. 736-739.
Shibayama et al., “Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues,” Am. J. Pathol., vol. 248, No. 6 (1996) pp. 1807-1818.
Sommerfeld et al., “Down regulation of the neurotrophin receptor TrkB following ligand binding,” J. Biol. Chem., vol. 275, No. 12 (Mar. 24, 2000) pp. 8982-8990.
Tessarollo, “Peiotropic functions of neurotrophins in development,” Cytokine and Growth Factor Reviews, vol. 9, No. 2 (1998) pp. 125-137.
Vesa et al., “p75 Reduces TrkB tyrosine autophosphorylation in response to brain-derived neurotrophic factor and neurotrophin 4/5,” J. Biol. Chem., vol. 275, No. 32 (Aug. 11, 2000) pp. 24414-24420.
Waraksa et al., “Neurotrophin-3 augments steroid secretion by hamster ovarian folliclesin vitro,” Zoolog Sci., vol. 12, (1995) pp. 499-502.
Yamamoto et al., “Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3 and CDNF) and their receptors (p75NGFR, Trk A, Trk B and Trk C) in the adult human peripheral nervous system and nonneural tissues,” Neurochemical Research, vol. 21, No. 8 (1995) pp. 929-938.
Zaccaro et al., “p75 co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains,” J. Biol. Chem., vol. 276, No. 33 (Agu. 17, 2001) pp. 31023-31029.
Dreyfus Cheryl
Feng Bo
Seifer David B.
Shelden Robert
Borgeest Christina
Kemmerer Elizabeth C.
Licata & Tyrrell PC
University of Medicine and Dentistry of New Jersey
LandOfFree
Method of utilizing neurotrophins to manipulate reproductive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of utilizing neurotrophins to manipulate reproductive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of utilizing neurotrophins to manipulate reproductive... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3950394